Darunavir 300 mg
As a protease inhibitor designed for use in boosted antiretroviral regimens, Darunavir 300 mg Tablets are incorporated into combination therapy strategies for the treatment of HIV-1 infection, following established international treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg administered with an appropriate pharmacokinetic booster and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
120 tablets
Darunavir 300 mg
As a protease inhibitor designed for use in boosted antiretroviral regimens, Darunavir 300 mg Tablets are incorporated into combination therapy strategies for the treatment of HIV-1 infection, following established international treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg administered with an appropriate pharmacokinetic booster and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
120 tablets
Darunavir 300 mg
As a protease inhibitor designed for use in boosted antiretroviral regimens, Darunavir 300 mg Tablets are incorporated into combination therapy strategies for the treatment of HIV-1 infection, following established international treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg administered with an appropriate pharmacokinetic booster and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
120 tablets